Article
Dexamethasone inhibits maturation and alters function of monocyte-derived dendritic cells from cord blood.
Pediatric research - 1 Jul 2005
Mainali Elsie S, Kikuchi Takeshi, Tew John G
Abstract excerpt
Critically ill infants are treated with dexamethasone (Dx) and other glucocorticoids to reduce inflammation and to promote lung and cardiac function. The neonatal immune system is immature, so neonatal dendritic cells (DCs) might be especially sensitive to glucocorticoid-mediated immunosuppression. To test this, we compared Dx treatment of monocyte-derived DCs from cord (CB) and adult blood (AB). Dx decreased...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
